News
Rival companies trying to develop oral weight-loss candidates include Novo Nordisk, which has an oral formulation of ...
Pharma has so far been exempted from Trump's tariff blitz, which imposed a flat rate of 10% on imports from 5th April and ...
A complaint against GSK accusing it of a major breach of the pharma industry's code of practice on prescribing information ...
Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell ...
The Advisory Committee on Immunisation Practices (ACIP) has voted to widen the recommendations on the use of RSV shots to ...
The South San Francisco biotech has acquired rights to tralesinidase alfa, an enzyme replacement therapy (ERT) for the ...
Greater availability of real-world data and real-world evidence is rapidly changing the landscape of drug development.
The concerns were first raised in The Guardian, which highlighted that one in five requests to access the data is from ...
The EU approval comes after Eisai and Biogen were given approval for a new once-monthly intravenous maintenance dose of ...
By leveraging data, digitalisation, and artificial intelligence (AI), the network aims to transform its operations, making ...
In one move that will please the drug industry, Trump has promised to do away with the detested 'pill penalty', a shorter ...
Shares in Ironwood Pharma fell by a third after it revealed that the FDA is insisting on a new phase 3 trial of its short ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results